Literature DB >> 16246607

Spirocercosis-associated pyothorax in dogs.

Sigal Klainbart1, Michal Mazaki-Tovi, Neomi Auerbach, Itzhak Aizenberg, Yaron Bruchim, Gillian Dank, Eran Lavy, Itamar Aroch, Shimon Harrus.   

Abstract

The records of five dogs diagnosed with spirocercosis-associated pyothorax were retrospectively reviewed. On admission, the most common clinical findings were weakness, anorexia, depression, dyspnoea and fever. All dogs had typical oesophageal Spirocerca lupi granulomas. Contrast thoracic radiography revealed contrast material leakage from the oesophagus into the pleural cavity in two dogs only. All dogs were medically treated with broad-spectrum antibiotics, repeated chest tube drainage and thoracic lavage, and four of the dogs were treated with doramectin. One dog was euthanased due to a concurrent non-related disease at the owners request while the remaining four survived. S. lupi infection should be included in the differential diagnoses of canine pyothorax in endemic areas. Conservative medical management of pyothorax with antihelmintic medication was shown to be effective in the treatment of S. lupi-associated pyothorax.

Entities:  

Mesh:

Year:  2005        PMID: 16246607     DOI: 10.1016/j.tvjl.2005.08.019

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  2 in total

Review 1.  Biotechnological advances in the diagnosis of little-known parasitoses of pets.

Authors:  Donato Traversa; Domenico Otranto
Journal:  Parasitol Res       Date:  2008-12-06       Impact factor: 2.289

2.  Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study.

Authors:  Gilad Segev; Alicia Rojas; Eran Lavy; Marganit Yaffe; Itamar Aroch; Gad Baneth
Journal:  Parasit Vectors       Date:  2018-03-05       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.